top of page

About Dr Shu Ng

Dr Shu Ng (affectionately known as Dr Shu) graduated from Monash University in Melbourne, Australia in 2010 and has 10 years of postgraduate medical experience in various medical and surgical specialties. She undertook an 18-month Radiation Oncology research fellowship at Memorial Sloan Kettering Cancer Center in New York, USA, whilst completing her Master of Public Health (MPH) with University of Sydney. After her return to Melbourne, she spent 3 years in Radiation Oncology specialty training at Alfred Health and Peter MacCallum Cancer Centre, managing patients with cancers of the breast, prostate, bowel, pancreas, lung, brain, etc.

 

Dr Shu approaches her patients with kindness, compassion and holistic care. She is very passionate about helping patients undergoing cancer treatment or experiencing cancer-related symptoms, as well as managing symptoms in palliative care. She has broad interests within medicinal cannabis including managing chronic pain, mental health, women's health, neurodegenerative and seizure disorders and autism spectrum disorders.

Dr Shu is an Authorised Prescriber and to date has managed over 2000 patients and their journey with medicinal cannabis. Dr Shu is a member of the Society of Cannabis Clinicians (SSC), Society of Cannabis Clinicians Australian Chapter (SSCAC) and Australian & New Zealand College of Cannabinoid Practitioners (ANZCCP). She is also completing her multidisciplinary Fellowship with the Australasian Society of Lifestyle Medicine (ASLM).

In addition to medicinal cannabis, Dr Shu is also passionate about smoking cessation and tobacco harm reduction, and is an Authorised Prescriber of nicotine vaping products.

Outside of medicine, Dr Shu adopts a healthy and holistic lifestyle, and enjoys spending time with her partner Paul and two Italian Greyhounds Vino and Ava. 

In November 2021 and May 2024, Dr Shu gave a webinar presentation for Counterpart, an organisation supporting patients with breast and gynae cancers. You are welcome to watch the 2024 webinar here: Watch Video Webinar

bottom of page